The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “The dual promise of oncolytic viruses: selective targeting and therapeutic enhancement in cancer treatment”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Cillian H. Cheng, Chi Chun Wong. The mycobiome, virome and archaeome in gastrointestinal cancers: molecular pathogenesis and therapeutic intervention, Molecular Cancer. 2026; 25: 182. https://doi.org/10.1186/s12943-026-02698-3 |
|
2 |
2026 |
Mohammad Fayyad-Kazan, Sarah Al-Tameemi, Allal Ouhtit. Oncolytic Viruses in Cancer Immunotherapy: From Molecular Engineering to Clinical Translation, Cells. 2026; 15: 393. https://doi.org/10.3390/cells15050393 |
|
3 |
2026 |
Omid Salahi Ardekani, Mahya Zarezade, Behshid Meymandi, Narjes Azami, Bahar Mahdavi, Toran Shahani. Recent advances in oncolytic virotherapy: insights from clinical trials and combination treatment strategies, Virology Journal. 2026; 23: 187. https://doi.org/10.1186/s12985-026-03207-0 |
|
4 |
2026 |
André Mansinho, Joana Albuquerque, Emiliano Calvo. Oncolytic viruses and neoantigen vaccines: opportunities and challenges in priming antitumour immunity, The Lancet Regional Health - Europe. 2026; 64: 101659101659. https://doi.org/10.1016/j.lanepe.2026.101659 |
|
5 |
2026 |
Tanya Saxena, Shamsuz Zaman, Himanshu Dhanda, Sandeep Kumar Swain, Neetu Kushwaha, Manpreet Kaur, Raj Kamal, Sufian Zaheer, Pranay Tanwar, Neeraj Kumar, Fouzia Siraj, Bhavika Rishi, Aroonima Misra. Immunotherapy for Cancer: Current Advances and Future Directions, International Journal of Molecular Sciences. 2026; 27: 7216. https://doi.org/10.3390/ijms27167216 |
|
6 |
2026 |
Subham Das, Himakshi Rekha Goswami, Indrani Barman, Nayan Talukdar. Efficacy of oncolytic viruses (OVs) in malignant tumor therapy: a review on its therapeutic aspects, Clinica Chimica Acta. 2026; 589: 121017121017. https://doi.org/10.1016/j.cca.2026.121017 |